Tirofiban

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Tirofiban is a glycoprotein IIb/IIIa receptor blocker. The binding to the GPIIb-/IIIa-receptors is reversible

Indication
This section has been translated automatically.

Unstable angina pectoris and non-Q-wave infarction

You might also be interested in

Dermatology
Melanodermatitis toxica. solitary, chronically stationary (no growth dynamics), large-area, blurr...
Melanodermatitis toxica

Exogenously triggered, chronic phototoxic, partly also photoallergic reaction with post-inflammatory pigmen...

Continue reading
Advertisment

Dosage and method of use
This section has been translated automatically.

Initially 0.4 ug/kg/min over 30 minutes i.v., then 0.1 ug/kg/min over 48 hours

Preparations
This section has been translated automatically.

Aggrastat®

Literature
This section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Recommended articles

Advertisment
Vascular medicine
pyodermic ulcer of the skin: moderately deep, large ulcer; characteristic are the circulatory (as...
Leg ulcer

Polyetiological skin defect (symptom) on the lower leg, which extends into the dermis or subcutis. At least...

Continue reading
Advertisment
Vascular medicine
Teleangiectasia: harmless, linear, irregular vascular dilatation in the cheek area.
Teleangiectasia

Permanently dilated skin capillaries visible to the naked eye with a diameter of =/< 0.1 cm. Teleangiect...

Continue reading
Dermatology
Structural formula of benzyl nicotinate.
Benzyl nicotinate

Benzyl nicotinate is the benzyl ester of nicotinic acid with the molecular formula: C13H11NO2. Benzyl nicot...

Continue reading
Dermatology
Keratoma sulcatum

Bacterial, non-inflammatory infection of the sole of the foot with swelling of the horny layer, shallow dim...

Continue reading

Outgoing links (1)

Glycoprotein iib-/iiia receptor blockers (overview);

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer Prof. Dr. med. Peter Altmeyer

Articlecontent